Antithrombotic therapy for prevention of recurrent stroke in the new millennium.
Schneck
Michael J
MJ
Biller
Jose
J
D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D016032:Randomized Controlled Trials as Topic / Q000639:trends; D055502:Secondary Prevention; D020521:Stroke / Q000188:drug therapy / Q000517:prevention & control*
D005343:Fibrinolytic Agents